Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 133.6 USD 0.29% Market Closed
Market Cap: 232.4B USD

Intrinsic Value

The intrinsic value of one ABT stock under the Base Case scenario is 110.15 USD. Compared to the current market price of 133.6 USD, Abbott Laboratories is Overvalued by 18%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ABT Intrinsic Value
110.15 USD
Overvaluation 18%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Compare ABT to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Growing regulatory and reputational risks stemming from Abbott’s high-profile infant formula recalls could dampen consumer confidence and potentially lead to stricter oversight of its manufacturing facilities, hindering production and sales growth.

Bull Theses

Abbott has a leading position in the continuous glucose monitoring market, with its FreeStyle Libre products continuing to gain traction globally, positioning the company for strong long-term revenue growth in diabetes care.

Show More Less
How do you feel about ABT?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Abbott Laboratories
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Abbott Laboratories

Current Assets 23.7B
Cash & Short-Term Investments 8B
Receivables 6.9B
Other Current Assets 8.8B
Non-Current Assets 57.8B
Long-Term Investments 886m
PP&E 10.7B
Intangibles 29.8B
Other Non-Current Assets 16.5B
Efficiency

Free Cash Flow Analysis
Abbott Laboratories

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Abbott Laboratories

Revenue
42.3B USD
Cost of Revenue
-18.6B USD
Gross Profit
23.8B USD
Operating Expenses
-16.4B USD
Operating Income
7.4B USD
Other Expenses
6.1B USD
Net Income
13.5B USD
Fundamental Scores

ABT Profitability Score
Profitability Due Diligence

Abbott Laboratories's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Exceptional ROE
Positive 3Y Average ROE
Positive ROIC
Exceptional Gross Margin
61/100
Profitability
Score

Abbott Laboratories's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

ABT Solvency Score
Solvency Due Diligence

Abbott Laboratories's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
High Interest Coverage
72/100
Solvency
Score

Abbott Laboratories's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ABT Price Targets Summary
Abbott Laboratories

Wall Street analysts forecast ABT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABT is 144.51 USD with a low forecast of 121.32 USD and a high forecast of 166.95 USD.

Lowest
Price Target
121.32 USD
9% Downside
Average
Price Target
144.51 USD
8% Upside
Highest
Price Target
166.95 USD
25% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Jul 11, 2025
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for ABT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ABT Insider Trading
Buy and sell transactions by insiders

ABT News

Other Videos
What is the Intrinsic Value of one ABT stock?

The intrinsic value of one ABT stock under the Base Case scenario is 110.15 USD.

Is ABT stock undervalued or overvalued?

Compared to the current market price of 133.6 USD, Abbott Laboratories is Overvalued by 18%.

Back to Top